Skip to main content
. 2023 Oct 24;2023(10):CD014967. doi: 10.1002/14651858.CD014967.pub2

CTRI/2023/02/049794.

Study name Study comparing efficacy of two drugs as first line drug in late preterm and term babies with neonatal seizure
Methods Randomised controlled trial
Participants Term and preterm neonates apparently presenting with seizures (clinical diagnosis) lasting 3 min or more
Interventions Intervention 1: Levetiracetam: Injection of levetiracetam (40 mg/kg then 20 mg/kg) as 1st‐line drug in neonatal seizures given over 20 minutes
Control intervention 1: Phenobarbitone: Injection of phenobarbitone (20 mg/kg then 20 mg/kg) loading dose is the standard 1st‐line drug for neonatal seizures given over 20 minutes
Outcomes Termination of clinical seizures (seizure control in 60 minutes and no further seizure in 24 hours). Time point: Termination of clinical seizures (seizure control in 60 minutes and no further seizure in 24 hours)
Starting date  
Contact information bhupendra.gupta@tatasteel.com
Notes Clinical diagnosis of seizures and assessment of treatment success